Monrol will establish a legal entity and manufacturing facility in Germany
patients around the world
Monrol is one of the world’s largest nuclear medicine companies leading innovation for the development and manufacturing of GMP grade radioisotopes and radiopharmaceuticals having headquarters in Istanbul. Monrol is distributing its world- class radiopharmaceutical products portfolio with excellence in global markets.
Monrol is a CDMO, providing early development support to itscustomers as well as offering fully integrated services for today’s nimble, lean, virtual companies effectively taking new product concepts into clinical trials, demonstrating proof of concept and going into first-in-human studies. Monrol is committed to transform and improve patient journey in cancer treatment with its radiopharmaceutical products portfolio distributing to more than 60 countries around the globe.
OF THE BIGGEST
Our primary purpose is to provide “hope for a better life for cancer patients”. Through our values based on Innovation, Curiosity, Collaboration, Integrity, Courage & Agility, we are committed to our mission as a global supplier of targeted nuclear medicine products and a preferred partner for developing novel drugs. We are always powered by our Brave, Learning Organization, Strong Relationship, Sharing & Celebrating behaviours.